The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives

The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW‐ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment trials. It is a public‐private partnership that spans North America, Argentina, Australia, Canada, China,...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Christopher J., Carrillo, Maria C., Jagust, William, Jack, Clifford R., Shaw, Leslie M., Trojanowski, John Q., Saykin, Andrew J., Beckett, Laurel A., Sur, Cyrille, Rao, Naren P., Mendez, Patricio Chrem, Black, Sandra E., Li, Kuncheng, Iwatsubo, Takeshi, Chang, Chiung‐Chih, Sosa, Ana Luisa, Rowe, Christopher C., Perrin, Richard J., Morris, John C., Healan, Amanda M.B., Hall, Stephen E., Weiner, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719344/
https://www.ncbi.nlm.nih.gov/pubmed/35005206
http://dx.doi.org/10.1002/trc2.12226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719344/
https://www.ncbi.nlm.nih.gov/pubmed/35005206
http://dx.doi.org/10.1002/trc2.12226

Ejemplares similares